We focus on: p73 anti-cancer p63 anti-cancer p53 mutants in cancers
Meeting reports:
2020 12 21 Zhi Yu Bai Topic: Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway. Front Oncol. 2020 Feb 5;10:104.
2021 01 18 Wei Hsin Kuo Topic: The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418. PLoS One. 2019 May 23;14(5):e0216423.
2021 04 26 Ming Han Wu Topic: 2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations. Nat Commun. 2020 Mar 20;11(1):1509.
The following paper reports were held by the journal club.